Gene recombinant monoclonal antibody series pharmaceutical injection products are mainly used to treat: first, various tumors (such as metastatic breast cancer, prostate cancer, giant cell bone tumors); second, osteoporosis; third, rheumatoid joints inflammation and other symptoms. 1. It is a series of pharmaceutical injection products of genetically recombinant monoclonal antibodies, mainly used in the treatment of: first, various tumors (such as metastatic breast cancer, prostate cancer, giant cell bone tumors); second, osteoporosis; third, Rheumatoid arthritis and other symptoms. 2. Market prospects: After the project reaches full production, it can achieve annual sales revenue of 12 billion yuan, achieve annual tax revenue of more than 1 billion yuan, and arrange for more than 500 technical labor jobs.